Raghupathy “Siva” Sivakumar has been appointed as the university’s inaugural vice-president of commercialisation and chief commercialisation officer.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Cornell spinout Lexeo Therapeutics has added $100m to its coffers thanks to a series B round co-led by D1 Capital Partners and Eventide Asset Management.

Dundee spinout Exscientia is continuing a busy fundraising year with a filing for an IPO in the US and a $35m concurrent private placement.

Cardiff University has become the sixth institution to join the partnership, having already collaborated on one programme for three years.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Based on technology at University of Pennsylvania, iEcure has launched to commercialise gene therapies initially for liver disorders and an option to license more assets.

Keio’s synthetic silk producer increased its valuation to over $1.2bn in a round led by Carlyle Japan Partners.

Harvard spinout Emulate will use the cash to further develop its organ-on-a-chip technology, having now raised nearly $225m in total.

Parkwalk Advisors and Cambridge Innovation Capital have backed the pet antibody therapeutics developer, a spinout of Wellcome Sanger Institute.